Product
10-1074-LS-J
2 clinical trials
1 indication
Indication
HIV-1 infectionClinical trial
A Phase I, Randomized, Placebo-Controlled Study of the Safety, Antiviral & Immunomodulatory Activity of Broadly Neutralizing Antibodies 3BNC117-LS-J and 10-1074-LS-J in Combination in ART-treated Adults in Sub-Saharan Africa Living With HIV During a Monitored Analytical Treatment InterruptionStatus: Recruiting, Estimated PCD: 2025-06-30
Clinical trial
Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African AdultsStatus: Active (not recruiting), Estimated PCD: 2023-09-01